Swiss Biotech Stock News

Barry Callebaut (SWX:BARN) reported earnings that underscore a mixed picture. Revenue is projected to decline at 0.7% per year over the next three years, while current net profit margins have slipped to 1.3% from 1.8% last year. Over the last five years, the company’s earnings have fallen by 12.5% annually, and this past year included a CHF 79.6 million one-off loss. Despite the lackluster historical trend, future prospects look brighter, with analysts forecasting annual earnings growth of...

UBS Group (SWX:UBSG) shares have shown mixed signals over the past month, dipping slightly despite a solid year-to-date gain. Investors are closely watching recent trends to gauge where the stock could head next. See our latest analysis for UBS Group. UBS Group's recent 4.6% dip in 1-month share price return has not erased the tailwind from a strong year-to-date gain. Long-term investors have enjoyed a robust 190.7% total shareholder return over five years. Momentum appears to be shifting...

ABB (SWX:ABBN) shares have edged slightly lower this week, with a modest pullback over the past month following recent gains earlier in the year. Investors may be watching for fresh catalysts or business updates in the coming weeks. See our latest analysis for ABB. ABB’s 17.7% year-to-date share price return stands out, and while this past week saw a mild dip, momentum has hardly faded. Shareholders are still sitting on an impressive 17.5% total return over the past year and more than a 115%...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Tecan Group fair value estimate is CHF261 Tecan Group's CHF138...

Key Insights Medartis Holding's estimated fair value is CHF76.67 based on 2 Stage Free Cash Flow to Equity Current...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

You may think that with a price-to-sales (or "P/S") ratio of 0.3x ams-OSRAM AG ( VTX:AMS ) is a stock worth checking...

Burckhardt Compression Holding (SWX:BCHN) delivered earnings growth of 25.1% over the past year, notably outpacing its five-year average of 22.3% per year. Net profit margins advanced to 9.6% from last year’s 8.7%, and shares now trade at CHF542, still below the analyst fair value estimate of CHF682.96. With high quality earnings and expectations for continued, if slower, growth ahead, investors have plenty of reasons to view the latest results with optimism. However, dividend sustainability...

In October 2025, Sika AG announced new earnings guidance for 2026–2028, local currency sales growth targets, and reported nine-month 2025 results showing CHF 8,578.1 million in sales and CHF 869.9 million in net income, both lower than the previous year. The past month's developments also included expanding factory operations in Bangladesh and appointing a new General Manager in Romania, reflecting a push for regional growth and leadership transformation. We'll now examine how Sika's new...

Roche Holding (SWX:ROG) shares have caught the attention of investors following a recent shift in its valuation. With several key metrics offering mixed signals, many are taking a closer look at what is behind these moves. See our latest analysis for Roche Holding. Roche Holding’s share price has seen some turbulence lately, with a 1.73% gain in the last day partly offsetting recent declines, including a 7.95% drop over the past month. Despite short-term choppiness, its total shareholder...

Wondering whether ABB might be a bargain or just riding the wave? Here is a breakdown of what the numbers and recent events could mean for anyone curious about the stock’s real value. The stock has seen a strong run, climbing 18.3% year to date and up 177.8% over five years. There has been a slight dip of -2.5% in the past week. Recent news around ABB’s expansion into electrification solutions and investments in automation have powered investor optimism. At the same time, shifting...

As the European markets experience mixed performances, with the pan-European STOXX Europe 600 Index recently pulling back after reaching fresh highs, investor attention is increasingly turning towards growth companies with high insider ownership. In this environment, stocks that combine robust growth potential and significant insider investment can offer unique insights into confidence levels within a company, making them noteworthy for investors seeking opportunities in a fluctuating market...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Key Insights INFICON Holding's estimated fair value is CHF103 based on 2 Stage Free Cash Flow to Equity INFICON...

One simple way to benefit from the stock market is to buy an index fund. But if you choose individual stocks with...

With a price-to-sales (or "P/S") ratio of 0.4x Schweiter Technologies AG ( VTX:SWTQ ) may be sending bullish signals at...

With a median price-to-sales (or "P/S") ratio of close to 1.7x in the Electronic industry in Switzerland, you could be...

The main aim of stock picking is to find the market-beating stocks. But in any portfolio, there will be mixed results...

Swiss Prime Site AG's ( VTX:SPSN ) price-to-earnings (or "P/E") ratio of 25.7x might make it look like a sell right now...

Sika (SWX:SIKA) has just rolled out the Sika Carbon Compass, an automated tool designed to calculate product carbon footprints. This move aligns with the company’s focus on sustainability and new environmental standards. See our latest analysis for Sika. Even as Sika introduces forward-looking sustainability initiatives, the stock’s momentum has faded, with a 1-year total shareholder return of -36.5%. Recent earnings revealed both sales and profit slid compared to last year, and cautious new...

Ever find yourself wondering if Roche Holding is a hidden gem or just another pharmaceutical heavyweight trading at a premium? You are not alone. Today we are cutting through the noise to tackle exactly how to think about its value. Despite a recent 3.0% dip over the last week and a 9.5% slide in the past month, Roche Holding is still up 1.1% since the start of the year. This suggests the market is still weighing its long-term prospects against short-term bumps. Recent announcements about...

Novartis (SWX:NOVN) remains a steady presence in the pharmaceutical sector. Shares closed at 99.5 CHF, reflecting recent market movements that put the stock's performance into perspective for investors watching long-term trends. See our latest analysis for Novartis. Novartis has shown resilient momentum, with the share price pushing upwards nearly 12% year-to-date even after a recent dip. Its total shareholder return over the past three and five years, up 46% and 65% respectively, reflects...

Key Insights Bucher Industries' estimated fair value is CHF445 based on 2 Stage Free Cash Flow to Equity Current share...